Programa de detección y control de la infección y colonización de enterobacterias productoras de carbapenemasas en una Unidad de Cuidados Intensivos Pediátricos en Colombia

Chiotos, 2018, Increased 30-Day Mortality Associated With Carbapenem-Resistant Enterobacteriaceae in Children, Open Forum Infect Dis., 5, ofy222, 10.1093/ofid/ofy222 Logan, 2015, Carbapenem-Resistant Enterobacteriaceae in Children, United States, 1999-2012, Emerg Infect Dis., 21, 2014, 10.3201/eid2111.150548 Montagnani, 2016, Carbapenem-resistant Enterobacteriaceae Infections in Children: An Italian Retrospective Multicenter Study, Pediatr Infect Dis J., 35, 862, 10.1097/INF.0000000000001188 Nabarro, 2017, Clinical and Bacterial Risk Factors for Mortality in Children With Carbapenem-resistant Enterobacteriaceae Bloodstream Infections in India, Pediatr Infect Dis J., 36, e161, 10.1097/INF.0000000000001499 Akturk, 2016, Carbapenem-resistant Klebsiella pneumoniae colonization in pediatric and neonatal intensive care units: risk factors for progression to infection, Braz J Infect Dis., 20, 134, 10.1016/j.bjid.2015.12.004 Díaz, 2016, Clinical Characteristics of Carbapenem-resistant Klebsiella pneumoniae Infections in Ill and Colonized Children in Colombia, Pediatr Infect Dis J., 35, 237, 10.1097/INF.0000000000000987 Márquez-Herrera, 2016, Caracterización de pacientes conaislamiento de Klebsiella productora de carbapenemasa en un hospital pediátrico de tercernivel de Bogotá, Colombia, Infectio., 20, 231, 10.1016/j.infect.2015.11.001 Chiotos, 2017, Multicenter Study of the Risk Factors for Colonization or Infection with Carbapenem-Resistant Enterobacteriaceae in Children, Antimicrob Agents Chemother., 61, e01440, 10.1128/AAC.01440-17 Caselli, 2016, Infect Dis (Lond)., 48, 152, 10.3109/23744235.2015.1087647 Logan, 2015, Carbapenem-resistant enterobacteriaceae in children, United States, 1999-2012, Emerg Infect Dis., 21, 2014, 10.3201/eid2111.150548 Chiotos, 2016, Carbapenem-Resistant Enterobacteriaceae Infections in Children, Curr Infect Dis Rep., 18, 2, 10.1007/s11908-015-0510-9 Caselli D. Cesaro S. Fagioli F. Carraro F. Ziino O. Zanazzo G. et al. Incidence of colonization and bloodstream infection with carbapenem-resistant Enterobacteriaceae in children receiving antineoplastic chemotherapy in Italy. Infect Dis. 48. 152-155. doi:10.3109/23744235.2015.1087647 Tamma, 2018, Phenotypic detection of carbapenemase-producing organisms from clinical isolates, J Clin Microbiol., 56, e01140, 10.1128/JCM.01140-18 Gutiérrez, 2013, [Surveillance of carbapenem-resistant enterobacteria in stool cultures in a university hospital in Santiago, Chile], Rev Chilena Infectol., 30, 103, 10.4067/S0716-10182013000100019 Van Duin, 2013, Enterobacterias resistentes al carbapenem: una revisión del tratamiento y los resultados, Diagn Microbiol Infect Dis, 75, 115, 10.1016/j.diagmicrobio.2012.11.009 Hsu, 2014, Treatment of Multidrug-Resistant Gram-Negative Infections in Children, Clin Infect Dis., 58, 1439, 10.1093/cid/ciu069 Chiotos, 2020, Treatment of Carbapenem-Resistant Enterobacteriaceae Infections in Children, J Pediatric Infect Dis Soc., 9, 56, 10.1093/jpids/piz085 Maltezou, 2013, Infecciones causadas por patógenos gramnegativos resistentes a carbapenem en niños hospitalizados, Pediatr Infect Dis J., 32, e151, 10.1097/INF.0b013e3182804b49 Haeusler, 2013, Bacteriemia gramnegativa resistente a los antibióticos en pacientes de oncología pediátrica: factores de riesgo y resultados, Pediatr Infect Dis J., 32, 723, 10.1097/INF.0b013e31828aebc8 Oliveros Navarro, 2015, Bacteriemia por enterobacterias resistentes a carbapenems. Un estudio transversal, Infectio., 19, 60, 10.1016/j.infect.2014.11.006 Richter, 2017, Screening for carbapenem-resistant Enterobacteriaceae: who, when, and how?, Virulence., 19, 417, 10.1080/21505594.2016.1255381 Control Disease Center. Facility guidance for control of carbapenem-resistant Enterobacteriaceae (CRE). Up- date 2015. [consultado Dic 2021]. Disponible en: https://www.cdc.gov/hai/pdfs/cre/cre-gui- dance-508.pdf. Magiorakos, 2017, Infection prevention and control measures and tools for the preven- tion of entry of carbapenem-resistant Enterobacteriaceae into healthcare settings: guidance from the European Center for Disease Prevention and Control, Antimicrob Res Infect Control., 15, 113, 10.1186/s13756-017-0259-z European Center for Disease Prevention and Control (ECDC). Infection prevention and control and prepared- ness for COVID-19 in healthcare settings – Sixth up- date. 9 February 2021. ECDC: Stockholm; 2021. [consultado Dic 2021]. Disponible en: https://www.ecdc.europa.eu/sites/default/files/documents/Infection-prevention-and-control-in-healthcare-settings-COVID-19_6th_update_9_Feb_2021.pdf.